Navigating Innovation And Challenges In Cell And Gene Therapy Bioprocessing

Selecting the right processing tools for cell and gene therapies requires a nuanced balance of sterility, scalability, and consistency. Manufacturers must navigate the fine line between current "good enough" standards and the need for rigorous particle management that preserves cell integrity. As the industry shifts, understanding how autologous and allogeneic workflows dictate specific tooling requirements becomes essential for maintaining process consistency.

Beyond immediate operational needs, there is a pressing necessity to address regulatory gaps regarding ancillary materials and evaluate how artificial intelligence might soon reshape production efficiency. This discussion brings together expert perspectives to deconstruct these complex variables, offering strategies to optimize bioprocessing workflows for both current demands and future innovations. Watch the full presentation to deepen your understanding of these critical bioprocessing strategies.